Drug-induced pneumonitis caused by sulfamethoxazole, trimethoprim during treatment of Pneumocystis carinii pneumonia in a patient with refractory ulcerative colitis

Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 578-581

  Oshitani, Nobuhide ^a   Matsumoto, Takayuki ^a   Moriyama, Yoshinori ^a   Kudoh, Shinzo ^a   Hirata, Kazuto ^a   Kuroki, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroids; Drug induced pneumonitis; Pneumocystis carinii; Ulcerative colitis

Indexed keywords

BECLOMETASONE DIPROPIONATE; CD4 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; SULFONAMIDE;

ADULT; ARTICLE; CASE REPORT; HUMAN; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; MALE; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; COLITIS, ULCERATIVE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PNEUMONIA; PNEUMONIA, PNEUMOCYSTIS; SULFAMETHOXAZOLE; TRIMETHOPRIM;

EID: 0031815266     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050137     Document Type: Article

References (15)

1. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;I:1067-1070.
2. Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 1992;327:1853-1860.
3. Ioannidis JPA, Cappelleri JC, Skolnik PR, et al. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 1996;156:177-188.
4. Oshitani N, Kitano A, Matsumoto T, Kobayashi K. Corticosteroids for the management of ulcerative colitis. J Gastroenterol 1995;30(Suppl 8):118-120.
5. Guzman J, Wang Y-M, Teschler H, et al. Phenotypic analysis of bronchoalveolar lavage lymphocytes from acquired immunodeficiency patients with and without Pneumocystis carinii pneumonia. Acta Cytol 1992;36:900-904.
6. Siminski J, Kidd P, Phillips GD, et al. Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1991;143:437-440.
7. Leatherman JW, Michael AF, Schwartz BA, Hoidal JR. Lung T cells in hypersensitivity pneumonitis. Ann Intern Med 1984; 100:390-392
8. Pesci A, Bertorelli G, Marchioni M. T-lymphocytosis in bronchoalveolar lavage fluid of hypersensitivity pneumonitis. Chest 1985; 87:133-134.
9. Martin WJ II, Williams DE, Dines DE, Sanderson DR. Interstitial lung disease: Assessment by bronchoalveolar lavage. Mayo Clin Proc 1983;58:751-757.
10. Akoun GM, Mayaud CM, Milleron BJ, Perrot JY. Drug-related pneumonitis and drug-induced hypersensitivity pneumonitis. Lancet 1984;1:1362.
11. Costabel U, Schmitz-Schumann M, Matthys H. Bronchoalveolar T-cell subsets in gold lung. Evidence for a hypersensitivity reaction. Chest 1985;87:135.
12. Akoun GM, Cadranel JL, Milleron BJ, et al. Bronchoalveolar lavage cell data in 19 patients with drug-associated pneumonitis (except amiodarone). Chest 1991;99:98-104.
13. Brutinel WM, Martin WJ II. Chronic nitrofurantoin reaction associated with T-lymphocyte alveolitis. Chest 1986;89:150-152.
14. White DA, Rankin JA, Stover DE, et al. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989;139:18-21.
15. Lee HJ, Soliman MRI. Anti-inflammatory steroids without pituitary-adrenal suppression. Science 1982;215:989-991.